Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.

Autor:	Axcrona, Karol1, Aaltomaa, Sirpa2, da Silva, Carlos Martins3, Özen, Haluk4, Damber, Jan-Erik5, Tankó, László B.6, Colli, Enrico6, Klarskov, Peter7
Zdroj:	BJU International. Dec2012, Vol. 110 Issue 11, p1721-1728. 8p. 1 Diagram, 2 Charts, 3 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu